NMD4C and MDC Launch Postdoctoral Fellowship Funding Competition

The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) are excited to announce the launch of a funding competition to award two postdoctoral fellowships in neuromuscular disease (NMD) research!

The fellowship provides salary support for early-career scientists to conduct postdoctoral studies in a laboratory focused on research of NMDs, with successful applicants being eligible to receive up to $40 000 in funding over a one-year period. The fellowship will allow early-career scientists to pursue NMD-related research that will impact the understanding of the biological causes and/or new clinical treatment of NMDs while also supporting the recipients to pursue future independent research careers in the field of NMDs.

The competition is open as of September 1st, 2021 with the deadline for submissions being October 15, 2021 at 11:59 PM ET. The fellowship guidelines are available here, and we encourage all who are eligible to apply.

The fellowship will provide opportunities for early-career scientists to pursue exciting research in NMDs. Reducing barriers to practice in neuromuscular research is integral in allowing researchers to build a sustainable career in the field, and we are pleased to partner with Muscular Dystrophy Canada in providing these opportunities.

Dr. Rashmi Kothary, Steering Committee Member of the NMD4C

The NMD4C and MDC are committed to empowering the next generation of  early-career researchers and clinicians in building successful careers in NMD research and clinical practice. When provided with access to research funding and clinical fellowship opportunities, researchers and clinicians are more likely to develop core competencies, perform meaningful research and make long-term commitments to the field of NMDs. Empowering the next generation of researchers today will lead to improved neuromuscular care, research, treatment, and health outcomes for all Canadians tomorrow.

This initiative will assist with training and education for the next generation of neuromuscular researchers and strengthens the biomedical infrastructure to build neuromuscular research capacity in Canada. For our clients, this means we are investing in the sustainability of neuromuscular research which brings us one step closer to finding cures.

Stacey Lintern, CEO of Muscular Dystrophy Canada

This collaborative award is the first created by the NMD4C and MDC, with both organizations planning to announce a second fellowship in the coming months which will support early-career clinicians who wish to pursue a fellowship in the neuromuscular field. Stay tuned to NMD4C and MDC updates for more information to come later this fall!

Please don’t hesitate to share this opportunity with any of your colleagues and within your neuromuscular networks. For further inquiries, please contact Dr. Homira Osman (MDC) at or Dr. Erin Beattie (NMD4C) at .

 

Guidelines on how to apply are available here.

The application is available here.

 

 

 

 

Fellowship_webBanner

Read next...

2024 Dr David Green Award winners from MDC

NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards

We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.

NMD4C logo with text reading 'Canadian neuromuscular clinical trials network', MDC and IMHA logos at bottom.

NMD4C Launch Canadian Neuromuscular Clinical Trial Network

We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.

Event organizers and participants from SMA outcome measures training, March 2024 in Quebec.

Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network

This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted. 

MDC award $900 000 towards clinical and translational research projects in 2024.

MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.

SMA outcome measures training graphic

SMA Outcome Measures Training for Physiotherapists and Occupational Therapists

To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.

Congratulations to the 2024 early career award winners. Dr Mireille Khacho and Dr Jean-Philippe Leduc Gaudet.

Congratulations to the 2024 NMD4C Early Career Awards Recipients

We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.